
Chris Meekins
researcherMale0.0Global Dominance: 0.00%
Chris Meekins is a managing director of health policy research at Raymond James, where he provides insights and analysis on healthcare policy, particularly regarding pharmaceutical pricing and market dynamics. He is known for his critical evaluations of healthcare initiatives, including those related to drug pricing reforms introduced during the Trump administration.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Chris Meekins, managing director of health policy research at Raymond James, stated that drugmakers have been willing to do these deals because they realize that they are 'largely inconsequential' to their profit margins.
US drug prices: Trump announces ‘most favored nation’ deals with nine drug companiesCNN·
United States· 2025-12-19

